EGFR and neoplasm: Multivariate Cox proportional hazard model was used to assess the risk of relapse and overall survival in patients with different EGFR/cMET expression and activation patterns after controlling for demographic and clinico-pathological variables including age, tumor stage, nodal status, receptor subtype and histologic grade.